HealthHCV is conducting a brief survey to assess availability and access to HCV services during the COVID-19 pandemic. This two-minute survey will assist HealthHCV in developing HCV education and training that is most tailored for healthcare providers during this unprecedented time. All individual data will be confidential and reported in aggregate only.

Question Title

* 1. What type of healthcare provider are you? (Select all that apply.)

Question Title

* 2. What type of setting do you practice in?

Question Title

* 3. Where is your practice setting located?

Question Title

* 4. How has COVID-19 impacted your delivery of hepatitis C (HCV) services?

  Significantly decreased Somewhat decreased No change Somewhat increased Significantly increased N/A
HCV prevention (e.g. harm reduction, syringe services)
HCV screening
HCV treatment

Question Title

* 5. Since the onset of COVID-19, how have you delivered the following HCV services?

  Through telemedicine In person Both through telemedicine and in person Not conducting these services due to pandemic Not conducting these services due to other reason (e.g. recent change in funding)
HCV prevention (e.g. harm reduction, syringe services)
HCV screening
HCV treatment

Question Title

* 6. How has COVID-19 interrupted HCV prevention services? (Select all that apply.)

Question Title

* 7. How has COVID-19 interrupted HCV screening and linkage to care services? (Select all that apply.)

Question Title

* 8. Has COVID-19 caused interruptions in HCV treatment among existing clients with HCV?

Question Title

* 9. Are you currently taking on new HCV patients during COVID-19 practice disruptions?

Question Title

* 10. How has COVID-19 interrupted HCV treatment services? (Select all that apply.)

Question Title

* 11. How has your practice setting adapted delivery of services to continue to provide accessible HCV screening and treatment services? (Select all that apply.)

Question Title

* 12. What is your biggest concern for how COVID-19 will impact health outcomes of your patients living with or at risk for HCV?

0 of 13 answered
 

T